Terumo ROE 2012-2019 | TRUMY

Current and historical return on equity (ROE) values for Terumo (TRUMY) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Terumo ROE for the three months ending June 30, 2019 was 0.00%.
Terumo ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-06-30 $0.61B $6.29B 11.84%
2018-06-30 $0.53B $5.51B 10.91%
2017-06-30 $0.40B $4.53B 8.46%
2016-06-30 $0.36B $4.42B 7.29%
2015-06-30 $0.39B $4.82B 7.72%
2015-03-31 $0.36B $5.24B 6.98%
2014-12-31 $0.29B $5.09B 5.68%
2014-09-30 $0.36B $5.15B 7.11%
2014-06-30 $0.33B $4.87B 6.79%
2014-03-31 $0.34B $4.96B 7.02%
2013-12-31 $0.64B $5.11B 12.92%
2013-09-30 $0.59B $4.75B 12.16%
2013-06-30 $0.57B $4.66B 11.86%
2013-03-31 $0.58B $5.30B 12.36%
2012-12-31 $0.34B $4.74B 7.51%
2012-09-30 $0.27B $4.39B 6.12%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $24.016B $5.395B
Terumo Corporation is engaged in the manufacture and sales of medical products and equipment. The products offered by the Company covers General Hospital Products, Cardiac & Vascular Products, Blood Transfusion Products and Consumer Healthcare Products. General hospital products offered by it include Disposable Medical Equipment, Medical Electronic Products, Diabetes Care Products, CAPD Systems and Pharmaceuticals; Cardiac & Vascular Products include Interventional Systems, Cardiovascular Systems and Artificial Vascular Grafts. Terumo's Blood Transfusion products include blood bags, blood filter, filter in line, blood administration sets and apheresis, while consumer healthcare products include ear thermometer, electronic thermometer, basal body thermometer, electronic sphygmomanometer, urine test strip and leg compression stockings. Terumo Corporation is headquartered in Tokyo, Japan.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $139.646B 24.44
Medtronic (MDT) Ireland $135.351B 18.19
Stryker (SYK) United States $72.986B 23.59
Boston Scientific (BSX) United States $52.944B 23.85
Baxter (BAX) United States $43.025B 26.09
Lonza Group Ag (LZAGY) Switzerland $30.160B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $29.680B 0.00
Coloplast (CLPBY) Denmark $29.333B 45.27
Zimmer Biomet Holdings (ZBH) United States $28.886B 17.78
ResMed (RMD) United States $23.532B 40.88
Smith & Nephew SNATS (SNN) United Kingdom $20.258B 0.00
Sunny Optical Technology (SNPTF) China $17.572B 0.00
Insulet (PODD) United States $11.551B 706.73
Bio-Rad Laboratories (BIO) United States $10.800B 50.46
William Demant Holdings (WILYY) Denmark $7.896B 0.00
GN STORE NORD (GNNDY) Denmark $7.537B 38.94
Perrigo (PRGO) Ireland $7.053B 12.86
Hill-Rom Holdings (HRC) United States $6.647B 19.12
DiaSorin S.p.A (DSRLF) Italy $6.446B 0.00
Canopy Growth (CGC) Canada $6.442B 0.00
Haemonetics (HAE) United States $5.501B 33.86
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
ICU Medical (ICUI) United States $4.142B 27.18
Envista Holdings (NVST) United States $4.140B 0.00
NuVasive (NUVA) United States $3.433B 26.54
Neogen (NEOG) United States $3.353B 55.81
Quidel (QDEL) United States $3.229B 28.35
GW Pharmaceuticals (GWPH) United Kingdom $3.227B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.121B 0.00
Agios Pharmaceuticals (AGIO) United States $3.055B 0.00
National Vision Holdings (EYE) United States $2.822B 47.54
Aurora Cannabis (ACB) Canada $1.695B 0.00
AtriCure (ATRC) United States $1.602B 0.00
Cardiovascular Systems (CSII) United States $1.335B 0.00
NanoString Technologies (NSTG) United States $1.282B 0.00
TG Therapeutics (TGTX) United States $1.235B 0.00
InMode (INMD) Israel $1.053B 0.00
Phibro Animal Health (PAHC) United States $1.038B 20.54
Aphria (APHA) $0.934B 0.00
VAREX IMAGING (VREX) United States $0.909B 18.88
PetIQ (PETQ) United States $0.899B 21.94
Cerus (CERS) United States $0.840B 0.00
Quanterix (QTRX) United States $0.665B 0.00
DFB Healthcare Acquisitions (AHCO) United States $0.662B 126.31
Eagle Pharmaceuticals (EGRX) United States $0.642B 24.57
Lantheus Holdings (LNTH) United States $0.614B 13.96
LeMaitre Vascular (LMAT) United States $0.594B 33.79
Omeros (OMER) United States $0.591B 0.00
MacroGenics (MGNX) United States $0.496B 0.00
Surmodics (SRDX) United States $0.481B 55.34
Zynex (ZYXI) United States $0.390B 42.57
Owens & Minor (OMI) United States $0.385B 14.26
OraSure Technologies (OSUR) United States $0.370B 46.15
Organigram Holdings (OGI) Canada $0.363B 0.00
Repro-Med Systems (KRMD) United States $0.356B 225.00
Meridian Bioscience (VIVO) United States $0.349B 14.07
HEXO (HEXO) $0.335B 0.00
Utah Medical Products (UTMD) United States $0.335B 23.82
BioLife Solutions (BLFS) United States $0.298B 121.58
Evolus (EOLS) United States $0.288B 0.00
Female Health (VERU) United States $0.278B 0.00
Bovie Medical (APYX) United States $0.226B 0.00
InfuSystems Holdings (INFU) United States $0.206B 1037.00
Vapotherm (VAPO) United States $0.193B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.191B 0.00
Viemed Healthcare (VMD) United States $0.190B 20.00
Rockwell Medical (RMTI) United States $0.187B 0.00
United Health Products (UEEC) United States $0.176B 0.00
Cytosorbents (CTSO) United States $0.170B 0.00
Fonar (FONR) United States $0.132B 9.58
Liberty Health Sciences (LHSIF) Canada $0.131B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.113B 0.00
Chimerix (CMRX) United States $0.107B 0.00
MTech Acquisition (KERN) United States $0.094B 0.00
Surface Oncology (SURF) United States $0.074B 0.00
United-Guardian (UG) United States $0.074B 18.60
Oramed Pharmaceuticals (ORMP) United States $0.070B 0.00
Chembio Diagnostics (CEMI) United States $0.070B 0.00
Nephros (NEPH) United States $0.066B 0.00
FSD PHARMA INC (HUGE) Canada $0.040B 0.00
NF Energy Saving (BIMI) China $0.038B 0.00
GUARDION HEALTH (GHSI) United States $0.035B 0.00
ImmuCell (ICCC) United States $0.035B 0.00
Trinity Biotech (TRIB) Ireland $0.026B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.013B 0.00
Senestech (SNES) United States $0.006B 0.00
Capricor Therapeutics (CAPR) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00
Myomo (MYO) United States $0.003B 0.00
Akers Biosciences Inc (AKER) United States $0.001B 0.00